Sequential effects of daily arsenic trioxide treatment on essential and nonessential trace elements in tissues in mice

Anti-Cancer Drugs

Volumn 19, Issue 8, 2008, Pages 812-818

  Molin, Ylva ^a   Frisk, Peter ^b   Ilbäck, Nils Gunnar ^a,c  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c NATIONAL FOOD ADMINISTRATION   (Sweden)

Author keywords

Acute promyelocytic leukaemia treatment; Arsenic trioxide; Serum; Tissues; Trace elements

Indexed keywords

ARSENIC; ARSENIC TRIOXIDE; CADMIUM; COPPER; IRON; MAGNESIUM; MERCURY; SELENIUM; TRACE ELEMENT; ZINC; ANTINEOPLASTIC AGENT; ORGANOARSENIC DERIVATIVE; OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; DRUG EFFECT; DRUG TISSUE LEVEL; FEMALE; HEART; INTESTINE; KIDNEY; LIVER; LUNG; MASS SPECTROMETRY; MOUSE; NONHUMAN; PANCREAS; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; ANIMAL; BAGG ALBINO MOUSE; FOOD ANALYSIS; METABOLISM; TISSUE DISTRIBUTION; WATER SUPPLY;

ANIMALS; ANTINEOPLASTIC AGENTS; ARSENICALS; FOOD ANALYSIS; MICE; MICE, INBRED BALB C; OXIDES; TISSUE DISTRIBUTION; TRACE ELEMENTS; WATER SUPPLY;

EID: 53749099014     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/CAD.0b013e32830c456b     Document Type: Article

References (33)

1. Anetor JI, Wanibuchi H, Fukushima S. Arsenic exposure and its health effects and risk of cancer in developing countries: micronutrients as host defence. Asian Pac J Cancer Prev 2007; 8:13-23.
2. Dilda PJ, Hogg PJ. Arsenical-based cancer drugs. Cancer Treat Rev 2007; 33:542-564.
3. Tallman MS. Treatment of relapsed or refractory acute promyelocytic leukemia. Best Pract Res Clin Haematol 2007; 20:57-65.
4. Gailer J. Arsenic-selenium and mercury-selenium bonds in biology. Coordin Chem Rev 2007; 251:234-254.
5. Lindgren A, Vahter M, Dencker L. Autoradiographic studies on the distribution of arsenic in mice and hamsters administered 74As-arsenite or-arsenate. Acta Pharmacol Toxicol (Copenh) 1982; 51:253-265.
6. Uthus EO. Arsenic essentiality: a role affecting methionine metabolism. J Trace Elem Exp Med 2003; 16:345-355.
7. Bremner I, Beattie JH. Metallothionein and the trace minerals. Annu Rev Nutr 1990; 10:63-83.
8. Hidalgo J, Aschner M, Zatta P, Vasak M. Roles of the metallothionein family of proteins in the central nervous system. Brain Res Bull 2001; 55:133-145.
9. Nordberg M, Nordberg GF. Toxicological aspects of metallothionein. Cell Mol Biol (Noisy-le-grand) 2000; 46:451-463.
10. Toyama M,Yamashita M, Hirayama N, Murooka Y. Interactions of arsenic with human metallothionein-2. J Biochem 2002; 132:217-221.
11. Kreppel H, Bauman JW, Liu J, McKim JM Jr, Klaassen CD. Induction of metallothionein by arsenicals in mice. Fund Appl Toxicol 1993; 20: 184-189.
12. Goering PL, Klaassen CD. Altered subcellular distribution of cadmium following cadmium pretreatment: possible mechanism of tolerance to cadmium-induced lethality. Toxicol Appl Pharmacol 1983; 70:195-203.
13. Goyer RA. Toxic and essential metal interactions. Annu Rev Nutr 1997; 17:37-50.
14. Levander OA, Baumann CA. Selenium metabolism. V. Studies on the distribution of selenium in rats given arsenic. Toxicol Appl Pharmacol 1966; 9:98-105.
15. Zeng H, Uthus EO, Combs GF Jr. Mechanistic aspects of the interaction between selenium and arsenic. J Inorg Biochem 2005; 99:1269-1274.
16. Schrauzer GN. Effects of selenium antagonists on cancer susceptibility: new aspects of chronic heavy metal toxicity. J UOEH 1987; 9 (Suppl): 208-215.
17. Gailer J, George GN, Pickering IJ, Prince RC, Younis HS, Winzerling JJ. Biliary excretion of [(GS)(2)AsSe](-) after intravenous injection of rabbits with arsenite and selenate. Chem Res Toxicol 2002; 15:1466-1471.
18. Del Razo LM, Quintanilla-Vega B, Brambila-Colombres E, Calderon-Aranda ES, Manno M, Albores A. Stress proteins induced by arsenic. Toxicol Appl Pharmacol 2001; 177:132-148.
19. Benyamin G, Lindh U, Frisk P, Friman G, Ilback NG. Arsenic is decreased in target organs during viral infection in mice. J Trace Elem Med Biol 2006; 20:121-126.
20. Andrew A, Jewell D, Mason R, Whitfield M, Moore J, Karagas M. Drinking water arsenic exposure modulates gene expression in human lymphocytes from a U.S. population. Environ Health Perspect 2008; 116:524-531. doi: 10.1289/ehp.10861 available via http://dx.doi.org/ [Online 23 January 2008].
21. Lu DP, Qiu JY, Jiang B, Wang Q, Liu KY, Liu YR, et al. Tetra-arsenic tetrasulfide for the treatment of acute promyelocytic leukemia: a pilot report. Blood 2002; 99:3136-3143.
22. Vahter M. Mechanisms of arsenic biotransformation. Toxicology 2002; 181-182:211-217.
23. Douer D, Tallman MS. Arsenic trioxide: new clinical experience with an old medication in hematologic malignancies. J Clin Oncol 2005; 23:2396-2410.
24. Soignet SL, Frankel SR, Douer D, Tallman MS, Kantarjian H, Calleja E, et al. United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia. J Clin Oncol 2001; 19:3852-3860.
25. Miller WH Jr, Schipper HM, Lee JS, Singer J, Waxman S. Mechanisms of action of arsenic trioxide. Cancer Res 2002; 62:3893-3903.
26. Diaz Z, Laurenzana A, Mann KK, Bismar TA, Schipper HM, Miller WH Jr. Trolox enhances the anti-lymphoma effects of arsenic trioxide, while protecting against liver toxicity. Leukemia 2007; 21:2117-2127.
27. Mahieux R, Hermine O. In vivo and in vitro treatment of HTLV-1 and HTLV-2 infected cells with arsenic trioxide and interferon-alpha. Leuk Lymphoma2005; 46:347-355.
28. Zeng H, Combs GF Jr. Selenium as an anticancer nutrient: roles in cell proliferation and tumor cell invasion. J Nutr Biochem 2008; 19:1-7.
29. Ganther HE, Baumann CA. Selenium metabolism. I. Effects of diet, arsenic and cadmium. J Nutr 1962; 77:210-216.
30. Fraker PJ, King LE, Laakko T, Vollmer TL. The dynamic link between the integrity of the immune system and zinc status. J Nutr 2000; 130 (5S Suppl):1399S-1406S.
31. Driessen C, Hirv K, Kirchner H, Rink L. Zinc regulates cytokine induction by superantigens and lipopolysaccharide. Immunology 1995; 84:272-277.
32. Maitani T, Saito N, Abe M, Uchiyama S, Saito Y. Chemical form-dependent induction of hepatic zinc-thionein by arsenic administration and effect of co-administered selenium in mice. Toxicol Lett 1987; 39:63-70.
33. Kreppel H, Liu J, Liu Y, Reichl FX, Klaassen CD. Zinc-induced arsenite tolerance in mice. Fund Appl Toxicol 1994; 23:32-37.